ClinicalTrials.gg
RecruitingNCT06285877Updated Feb 29, 2024

Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury

An interventional study of Conventional therapy sessions and Conventional therapy sessions plus Nintendo Switch in Occupational Therapy, Acquired Brain Injury and Adults, sponsored by Universidad Rey Juan Carlos. Recruiting at 1 site in Spain. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2024-02-29.

Sponsored by Universidad Rey Juan Carlos · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 9 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Non-randomized
Ages
30 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 43 studies in Brain Injuries with a site in Spain — 11 open to participants now, 13 under way, none of them phase 3. Brain Injuries · Spain.

Planned enrollment
11th of 30
32 · median 30
Started
2024
with 4 others
No phase
27 of 43
8 open now
Primary completion
2024-02
later than 1 of 12 live
Registered
27th of 43
by date
Lead sponsor
2 of 43
Universidad Rey Juan Carlos

Among the 43 studies in Brain Injuries with a site in Spain, this one is the 11th largest by planned enrollment of the 30 interventional ones that give a count, is one of 5 that started in 2024, is one of 27 with no phase, reaches primary completion later than 1 of the 12 other live ones, and was the 27th registered.

Brain Injuries

947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.

Browse Brain Injuries studies →

Open to participants now

11 of the 43 studies in Brain Injuries with a site in Spain are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.

This study: 30 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Brain Injuries with a site in Spain, or all of them as a file.
02

Study summary

Purpose: to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction. The aim is to improve postural control in both seated and standing positions and to maintain and improve cognitive capacity.

Material and methods: one group (experimental group) will receive a total of 8 one-hour sessions or 16 half-hour sessions, depending on their individual needs, for 8 weeks using the Nintendo Switch. The other group (control group) will continue to receive their conventional scheduled therapy.

Measures: Abilhand, MEC-Lobo, FIST, Fugl-Meyer, Berg Balance Scale and CSQ-8.

03

Conditions studied

  • Occupational Therapy
  • Acquired Brain Injury
  • Adults

Browse trials for

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult men and women, over 30 years of age who have suffered an acquired brain injury.
  • Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35).
  • Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy).
  • Agree to participate voluntarily by signing the form.

Exclusion criteria

Exclusion Criteria:

  • Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35).
  • Present aphasia of comprehension or expression.
  • Present associated neurodegenerative pathology.
  • Present any pathology underlying the acquired brain damage (diabetes, heart disease, , etc.), heart disease, COPD, etc.).
  • Voluntarily refuse to participate in the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Active comparator
    Control Group

    Control Group (CG) which received their usual sessions of conventional therapy.

    Procedure: Conventional therapy sessions

  • Experimental
    Experimental Group

    Experimental Group (EG) which received therapy with Nintendo Switch plus their usual sessions of conventional therapy.

    Procedure: Conventional therapy sessions plus Nintendo Switch

Interventions

  • ProcedureConventional therapy sessions

    Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise.

  • ProcedureConventional therapy sessions plus Nintendo Switch

    Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise plus one hour a week of Nintendo Switch.

06

What researchers measure

Primary outcomes

  1. Abilhand

    It is an assessment test that measures the degree of difficulty perceived by the patient in performing the 23 activities of daily living.

    Time frame: Pre-intervention and post-intervention (up to 1-2 weeks)

  2. MEC-Lobo

    This is a scale that allows us to evaluate the cognitive status of patients. The lower the score, the greater the cognitive impairment.

    Time frame: Pre-intervention and post-intervention (up to 1-2 weeks)

  3. Function in Sitting Test (FIST)

    It is a scale that assesses the postural control deficits presented by the patient in sedentary position in the event of imbalance, reaching on the floor, etc.

    Time frame: Pre-intervention and post-intervention (up to 1-2 weeks)

  4. Fugl-Meyer

    This scale assesses the patient's motor function, sensory function, muscle balance, range of joint mobility and joint pain.

    Time frame: Pre-intervention and post-intervention (up to 1-2 weeks)

  5. Berg Balance Scale (BBS)

    The scale is used to measure balance mainly in standing position in patients with different types of pathologies.

    Time frame: Pre-intervention and post-intervention (up to 1-2 weeks)

Secondary outcomes

  1. Client Satisfaction Questionnaire (CSQ-8)

    Self-administered questionnaire that evaluates the level of satisfaction in relation to the care and quality of care received.

    Time frame: Post-intervention (up to 1-2 weeks)

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2024; primary completion for Feb 2024, 0 months later.

Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 0 months is below that.

Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2024
First posted
Feb 29, 2024
StartEst.
Feb 2024
Primary completionEst.
Feb 2024
CompletionEst.
Jan 2025
Last update
Feb 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06285877
Responsible party
Isabel Quirosa Galan (Occupational Therapist, MsC, Universidad Rey Juan Carlos) — Principal investigator
First posted
Feb 29, 2024
Start date
Feb 2024 (estimated)
Primary completion
Feb 2024 (estimated)
Completion
Jan 2025 (estimated)
Last update
Feb 29, 2024

Study contacts

Isabel Quirosa Galan, MsC
Contact
i.quirosa.2016@alumnos.urjc.es
+34655551210
Isabel Quirosa Galan, MsC
principal investigator · Universidad Rey Juan Carlos

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion